Market Tracker

08/01 6:05pm ET

Health Care Select Sector SPDR® Fund (XLV)

During the Trading Day
60.96 +0.05 / +0.08%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
60.96 0.00 / 0.00%
 
Volume: 700.3K

Investment Objective

The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Performance

1 month+0.12% 3 years+23.58%
3 months+5.14% 5 years+19.11%
1 year+21.26% Since inception+7.58%
Data through 08/01/2014

Quote Details

Previous close$60.91
Open day’s range60.50 – 61.27
Net asset value (NAV)60.91 (07/31/2014)
Daily volume16,923,843
Average volume (3 months)5,851,625
Data as of 4:00pm ET, 08/01/2014

Peer Comparisonvs. Health ETFs

 XLVCategory
Performance 5-yr return+19.11%+24.14%
Expense Gross exp ratio0.16%0.43%
Risk 5 year sharpe ratio1.641.52
Net assets$10.1B$1.4B
Average market cap$71.3B$25.9B
Average P/E24.126.1
Dividend / Share--0.21%

Competitors

VHT Vanguard Health Care ETF
IXJ iShares Global Healthcare ETF
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 98.28%
Hardware 1.15%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson12.69%
PFE Pfizer Inc8.12%
MRK Merck & Co Inc7.25%
GILD Gilead Sciences Inc5.46%
ABBV AbbVie Inc3.84%
AMGN Amgen Inc3.84%
BMY Bristol-Myers Squibb Company3.46%
UNH UnitedHealth Group Inc3.46%
BIIB Biogen Idec Inc3.28%
CELG Celgene Corp2.95%